文献速递神经肿瘤

人垂体腺瘤中环氧合酶2、程序性死亡配体1与精氨酸酶1的表达分析

Analysis of Cyclooxygenase 2, Programmed Cell Death Ligand 1, and Arginase 1 Expression in Human Pituitary Adenoma.
PubMed 文献 · World Neurosurg · 2020-09-10

该研究采用免疫组化检测55例垂体腺瘤样本中COX-2、PD-L1和ARG1的蛋白表达,以10例正常脑组织为对照,并用双重免疫荧光共定位和Western blot验证。结果显示三种蛋白在垂体腺瘤中表达均显著高于正常脑组织,且COX-2与PD-L1、ARG1表达正相关,PD-L1与ARG1表达正相关;ARG1在无功能垂体腺瘤中表达更高。结论提示三种蛋白过表达可能参与垂体腺瘤发病,COX-2可能通过上调PD-L1促进ARG1表达形成COX-2/PD-L1/ARG1信号通路。

要点

  • 垂体腺瘤中COX-2、PD-L1和ARG1蛋白表达均显著高于正常脑组织。
  • COX-2与PD-L1、ARG1表达正相关,PD-L1与ARG1表达正相关。
  • ARG1在无功能垂体腺瘤中表达高于功能型垂体腺瘤。

核心结论

  • COX-2、PD-L1和ARG1过表达可能参与垂体腺瘤的发病机制。
  • ARG1在无功能垂体腺瘤的发展中发挥更重要的作用。
  • COX-2可能通过上调PD-L1促进ARG1表达,形成COX-2/PD-L1/ARG1信号通路促进垂体腺瘤发生发展。

研究设计与样本

  • 免疫组化检测55例垂体腺瘤样本中COX-2、PD-L1和ARG1蛋白表达,以10例正常脑组织为对照。
  • 采用双重免疫荧光共定位研究三种蛋白在垂体腺瘤细胞中的定位。
  • 用Western blot进一步验证免疫组化结果。

主要发现

  • COX-2、PD-L1和ARG1在垂体腺瘤中的表达显著高于正常脑组织。
  • 功能型与无功能型垂体腺瘤间COX-2和PD-L1表达无显著差异,而ARG1在无功能型中更高。
  • COX-2蛋白表达水平与PD-L1和ARG1蛋白表达水平呈正相关,PD-L1表达与ARG1表达呈正相关。
  • 免疫荧光共聚焦显示COX-2、PD-L1和ARG1均表达于垂体腺瘤细胞胞质,三者物理位置部分重合。

临床怎么用

  • 提示COX-2/PD-L1/ARG1通路可能作为垂体腺瘤免疫逃逸机制研究的起点。
  • ARG1在无功能垂体腺瘤中表达更高,或可为该亚型研究提供方向。

局限性

  • 研究为初步理论探讨,需进一步在细胞和动物实验中验证免疫逃逸机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cyclooxygenase 2 (COX-2) is a key enzyme in the synthesis of prostaglandins. Recent studies have shown that overexpression of COX-2 can reduce the antitumor effect of the immune system by inhibiting the proliferation of B and T lymphocytes. Programmed cell death ligand 1 (PD-L1) was the first functionally characterized ligand of programmed cell death protein 1. It plays an important role in maintaining peripheral and central immune tolerance by combining with programmed cell death protein 1. Arginase 1 (ARG1) can process L-arginine in the local microenvironment and affect the function of T cells, resulting in immune escape. In this study, COX-2, PD-L1, and ARG1 expression in human pituitary adenoma (PA) and their relationship were investigated, which provided an initial theoretic basis for further study of the immune escape mechanism in PA in cellular and animal experiments. METHODS: The protein expression of COX-2, PD-L1, and ARG1 in 55 PA samples was detected by immunohistochemistry, with 10 normal brain tissues as the control group. The location of COX-2, PD-L1, and ARG1 in PA cells was studied by double immunofluorescence colocalization. The results of immunohistochemistry were further verified by Western blot. RESULTS: The expression of COX-2, PD-L1, and ARG1 in PA was significantly higher than that in normal brain tissue. In functional PA (FPA) and nonfunctional PA (NFPA), there was no significant difference in the expression of COX-2 and PD-L1, whereas ARG1 was higher in NFPA. Moreover, the protein expression level of COX-2 was positively correlated with that of PD-L1 and ARG1, and the expression of PD-L1 was positively correlated with that of ARG1. Immunofluorescence confocal imaging showed that COX-2, PD-L1, and ARG1 were all expressed in the cytoplasm of PA cells, and the physical positions of COX-2, PD-L1, and ARG1 were partially coincident. CONCLUSIONS: These findings indicate that overexpression of COX-2, PD-L1, and ARG1 may be involved in the pathogenesis of PA. ARG1 plays a more important role in the development of NFPA. By upregulating the expression of PD-L1, COX-2 may promote the expression of ARG1, forming the COX-2/PD-L1/ARG1 signal pathway in promoting the occurrence and development of PA. Perhaps further study of the pathogenesis of PA can start with the mechanism of immune escape.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhao G, Chen W, He J, et al. Analysis of Cyclooxygenase 2, Programmed Cell Death Ligand 1, and Arginase 1 Expression in Human Pituitary Adenoma. World Neurosurg. 2020. PMID: 32920160. doi:10.1016/j.wneu.2020.09.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。